Structures by: Kavitha T.
Total: 26
2-(5-Bromothiophen-2-yl)-1-phenyl-1<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole
C25H15BrN2S
IUCrData (2017) 2, 1 x170089
a=9.2966(4)Å b=23.0723(11)Å c=9.8089(4)Å
α=90° β=109.6630(10)° γ=90°
(3<i>R</i>,5<i>S</i>,7<i>R</i>,8<i>R</i>,9<i>S</i>,10<i>S</i>,12<i>S</i>,13<i>R</i>,14<i>S</i>)-10,13-Dimethyl-17-[5-oxo-5-(prop-2-yn-1-yloxy)pentan-2-yl]hexadecahydro-1<i>H</i>-cyclopenta[<i>a]</i>phenanthrene-3,7,12-triyl triacetate
C33H48O8
IUCrData (2017) 2, 3 x170436
a=9.7437(3)Å b=12.2437(3)Å c=26.8215(10)Å
α=90° β=90° γ=90°
1-Acetyl-2,6-bis(4-methoxyphenyl)-3-methyl-4-piperidone
C22H25NO4
Acta Crystallographica Section E (2007) 63, 8 o3648
a=17.2799(5)Å b=10.6783(3)Å c=10.5702(3)Å
α=90.00° β=90.9510(10)° γ=90.00°
N-Butylpyridine-4-thiocarboxamide
C10H14N2S
Acta Crystallographica Section E (2008) 64, 1 o114-o114
a=8.0895(3)Å b=13.5947(4)Å c=10.4936(3)Å
α=90.00° β=111.895(2)° γ=90.00°
3-Ethyl-2,6-bis(4-methoxyphenyl)piperidin-4-one
C21H25NO3
Acta Crystallographica Section E (2007) 63, 10 o3985-o3985
a=14.012(2)Å b=7.8060(14)Å c=17.655(3)Å
α=90.00° β=110.401(5)° γ=90.00°
1-Chloroacetyl-3,3-dimethyl-2,6-diphenylpiperidin-4-one
C21H22ClNO2
Acta Crystallographica Section E (2008) 64, 10 o2041
a=13.7005(3)Å b=9.8735(2)Å c=14.8960(3)Å
α=90.00° β=112.7620(10)° γ=90.00°
R-2,c-6-Bis(4-methoxyphenyl)-c-3,t-3-dimethyl-1-nitrosopiperidin-4-one
C21H24N2O4
Acta Crystallographica Section E (2009) 65, 6 o1420
a=7.2540(3)Å b=15.0469(6)Å c=17.0741(7)Å
α=90.00° β=90.00° γ=90.00°
Diethyl 2-[(5-methoxy-2-methyl-1-phenylsulfonyl-1<i>H</i>-indol-3-yl)methylene]malonate
C24H25NO7S
Acta Crystallographica Section E (2009) 65, 6 o1418-o1419
a=8.7597(2)Å b=10.9029(2)Å c=12.5186(3)Å
α=88.4020(10)° β=79.7230(10)° γ=83.635(2)°
3-(4-Methoxybenzyl)-2-methyl-1-phenylsulfonyl-1<i>H</i>-indole
C23H21NO3S
Acta Crystallographica Section E (2009) 65, 4 o847
a=11.4366(4)Å b=13.6021(5)Å c=14.0001(5)Å
α=74.1540(10)° β=67.773(2)° γ=88.848(2)°
1-Formyl-r-2,c-6-bis(4-methoxyphenyl)-c-3,t-3-dimethylpiperidin-4-one
C22H25NO4
Acta Crystallographica Section E (2009) 65, 4 o856
a=11.7274(3)Å b=18.8556(4)Å c=9.7178(3)Å
α=90.00° β=113.5070(10)° γ=90.00°
Diethyl 2-[(2-benzyl-1-phenylsulfonyl-1<i>H</i>-indol-3-yl)methylene]malonate
C29H27NO6S
Acta Crystallographica Section E (2009) 65, 1 o12
a=10.8280(9)Å b=13.7762(11)Å c=17.6832(16)Å
α=90.00° β=91.341(4)° γ=90.00°
1-Dichloroacetyl-3,3-dimethyl-2,6-diphenylpiperidin-4-one
C21H21Cl2NO2
Acta Crystallographica Section E (2009) 65, 1 o10
a=9.1084(2)Å b=10.8992(3)Å c=10.9918(3)Å
α=63.8790(10)° β=85.343(2)° γ=79.0290(10)°
T-3-Ethyl-r-2,c-6-bis(4-methoxyphenyl)-1-nitrosopiperidin-4-one
C21H24N2O4
Acta Crystallographica Section E (2009) 65, 8 o1765
a=7.2742(4)Å b=15.8459(7)Å c=16.4800(7)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-(3-ethoxy-4-hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate monohydrate
C15H18N2O5,H2O
Acta Crystallographica Section E (2009) 65, 8 o1921-o1922
a=11.4927(6)Å b=15.3756(8)Å c=8.9240(5)Å
α=90.00° β=95.932(2)° γ=90.00°
(<i>E</i>)-Methyl 3-(2-methyl-1-phenylsulfonyl-1<i>H</i>-indol-3-yl)but-2-enoate
C20H19NO4S
Acta Crystallographica Section E (2009) 65, 2 o431
a=8.9498(3)Å b=8.8427(2)Å c=23.2836(7)Å
α=90.00° β=97.0850(10)° γ=90.00°
Trimethyl 1-(2-methyl-1-phenylsulfonyl-1<i>H</i>-indol-3-yl)propane-1,2,3-tricarboxylate
C24H25NO8S
Acta Crystallographica Section E (2009) 65, 2 o264
a=11.0975(3)Å b=9.8255(3)Å c=22.0027(6)Å
α=90.00° β=98.605(2)° γ=90.00°
<i>tert</i>-Butyl 3-[2,2-bis(ethoxycarbonyl)vinyl]-2-methyl-1<i>H</i>-indole-1-carboxylate
C22H27NO6
Acta Crystallographica Section E (2009) 65, 4 o825
a=9.1933(3)Å b=21.8495(6)Å c=10.7676(3)Å
α=90.00° β=96.510(2)° γ=90.00°
1,1'-[4-(4-Methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-diyl]diethanone
C18H21NO3
Acta Crystallographica Section E (2009) 65, 11 o2795
a=12.0781(3)Å b=8.9650(2)Å c=29.3755(8)Å
α=90.00° β=90.00° γ=90.00°
<i>tert</i>-Butyl 3-[2,2-bis(ethoxycarbonyl)vinyl]-2-bromomethyl-1<i>H</i>-indole-1-carboxylate
C22H26BrNO6
Acta Crystallographica Section E (2009) 65, 11 o2796
a=10.8682(3)Å b=11.1094(4)Å c=11.5699(6)Å
α=111.984(3)° β=105.841(2)° γ=106.926(2)°
<i>c</i>-3,<i>t</i>-3-Dimethyl-4-oxo-<i>r</i>-2,<i>c</i>-6-diphenylpiperidine-1-carboxamide
C26H26N2O2
Acta Crystallographica Section E (2009) 65, 11 o2808
a=9.6648(2)Å b=10.7938(3)Å c=11.4233(3)Å
α=101.303(2)° β=90.1580(10)° γ=113.1910(10)°
1-Formyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)- <i>t</i>-3,<i>t</i>-5-dimethylpiperidin-4-one
C22H25NO4
Acta Crystallographica Section E (2009) 65, 11 o2818
a=11.0954(4)Å b=14.5407(3)Å c=12.7050(4)Å
α=90.00° β=110.9770(10)° γ=90.00°
1-Chloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>c</i>-3,<i>t</i>-3-dimethylpiperidin-4-one
C23H26ClNO4
Acta Crystallographica Section E (2009) 65, 11 o2793
a=12.5928(4)Å b=9.4141(3)Å c=17.9070(6)Å
α=90.00° β=90.8260(10)° γ=90.00°
(<i>E</i>)-<i>N</i>-Benzylidene-4<i>H</i>-1,2,4-triazol-4-amine
C9H8N4
Acta Crystallographica Section E (2010) 66, 3 o558
a=33.0059(11)Å b=4.06390(10)Å c=20.6535(7)Å
α=90.00° β=111.067(2)° γ=90.00°
Cyclohexane-1-spiro-2'-imidazolidine-5'-spiro-1''-cyclohexan-4'-one
C13H22N2O
Acta Crystallographica Section E (2010) 66, 5 o1072
a=5.8270(8)Å b=10.1703(5)Å c=10.6651(4)Å
α=86.103(2)° β=81.331(3)° γ=89.720(3)°
8,9-Dimethoxy-5-phenylsulfonyl-5<i>H</i>-benzo[<i>b</i>]carbazole
C24H19NO4S
Acta Crystallographica Section E (2010) 66, 5 o1071
a=7.8606(2)Å b=9.5892(2)Å c=13.8846(4)Å
α=100.3870(10)° β=93.168(2)° γ=105.8830(10)°
Ethyl 3-[2-(3,4-dimethoxybenzyl)-1-phenylsulfonyl-1<i>H</i>-indol-3-yl]acrylate chloroform hemisolvate
C28H27NO6S,0.5(CHCl3)
Acta Crystallographica Section E (2011) 67, 6 o1460-o1461
a=10.2154(3)Å b=12.0504(4)Å c=12.6310(4)Å
α=70.602(2)° β=69.6130(10)° γ=77.056(2)°